This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Medical Product Stocks to Trump Estimates in Q3 Earnings
by Zacks Equity Research
Here we analyze the favorable factors that are likely to boost results of medical product companies in Q3.
What's in Store for Tandem Diabetes' (TNDM) Q3 Earnings?
by Zacks Equity Research
Strong domestic sales along with the recent launch of the t:slim X2 Insulin Pump in selected international markets likely to drive Tandem Diabetes' (TNDM) Q3 earnings.
Can BD Medical Drive Becton, Dickinson's (BDX) Q4 Earnings?
by Zacks Equity Research
Becton, Dickinson (BDX) likely to gain from strong segmental contributions in fiscal Q4.
Why Quidel (QDEL) Could Beat Earnings Estimates Again
by Zacks Equity Research
Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are Options Traders Betting on a Big Move in Quidel (QDEL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Quidel (QDEL) stock based on the movements in the options market lately.
3 MedTech Stocks for Safe Returns as Hurricane Fears Peak
by Sweta Jaiswal
With the hurricane season at the peak, we bring three safe picks for investors.
3 Top Stocks From the Booming US Medical Products Industry
by Sreyoshi Mukherjee
The U.S. Medical Products industry is sturdy on solid focus on technological advancement.
Medical - Products Stock Outlook: Short-Term Pain Inevitable
by Zacks Equity Research
Near-term growth prospects of medical products are being questioned due to trade war apprehensions and President Trump's imposition of fresh tariffs on about $200 billion on Chinese imports.
Agios (AGIO) Assigns Ex-Celgene Executive to CEO Position
by Zacks Equity Research
Agios Pharmaceuticals (AGIO) names Dr. Jacqualyn Fouse as its next chief executive officer from Feb 1, 2019 onward.
Implied Volatility Surging for Quidel (QDEL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Quidel (QDEL) stock based on the movements in the options market lately.
Quidel (QDEL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Quidel (QDEL) delivered earnings and revenue surprises of 63.64% and 0.98%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Quidel (QDEL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Quidel (QDEL) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Quidel (QDEL) Stock?
by Zacks Equity Research
Investors in Quidel (QDEL) need to pay close attention to the stock based on moves in the options market lately.
Implied Volatility Surging for Quidel (QDEL) Stock Options
by Zacks Equity Research
Quidel (QDEL) needs investors to pay close attention to the stock based on moves in the options market lately.
Options Traders Expect Huge Moves in Quidel (QDEL) Stock
by Zacks Equity Research
Surging implied volatility makes Quidel (QDEL) stock lucrative to the option traders.
Implied Volatility Surging for Quidel (QDEL) Stock Options
by Zacks Equity Research
Investors in Quidel (QDEL) need to pay close attention to the stock based on moves in the options market lately.
Top Ranked Momentum Stocks to Buy for October 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 16th:
5 MedTech Momentum Picks Investors Will Love
by Zacks Equity Research
In a volatile political environment, seasoned investors should focus on momentum stocks as winning bets to tide over the uncertainty.
Quidel Corporation (QDEL) Jumps: Stock Rises 6.5%
by Zacks Equity Research
Quidel Corporation (QDEL) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Quidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session
by Zacks Equity Research
Quidel Corporation (QDEL) shares jumped above 25% in the last trading session.
Hill-Rom's Innovations Make Surgeries More Safe, Accurate
by Zacks Equity Research
Hill-Rom Holdings, Inc. (HRC) recently demonstrated the impact of surgical patient positioning on skin and nerve pressure-related injuries.
PetMed Faces Concerns over New Order Sales, Competition
by Zacks Equity Research
On Apr 6, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).
Omnicell's Aesynt Buyout Looks Promising amid Several Woes
by Zacks Equity Research
On Apr 6, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).
Strength Seen in Alere (ALR): Stock Adds 9.4% in Session
by Zacks Equity Research
Alere Inc. (ALR) shares rose over 9% in the last trading session.
Zacks.com featured highlights: Heska, Quidel, Trinseo S.A., Advanced Energy Industries and Pioneer Natural Resources
by Zacks Equity Research
Zacks.com featured highlights: Heska, Quidel, Trinseo S.A., Advanced Energy Industries and Pioneer Natural Resources